![Dawn Benson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dawn Benson
Keine laufenden Positionen mehr
Profil
Dawn Benson worked as a Director of Quality Assurance & Control at Haemacure Corp.
and as a Senior Manager of Quality Assurance at Jazz Pharmaceuticals, Inc. She obtained an undergraduate degree from The University of North Carolina at Wilmington.
Ehemalige bekannte Positionen von Dawn Benson
Unternehmen | Position | Ende |
---|---|---|
Haemacure Corp.
![]() Haemacure Corp. Industrial SpecialtiesProcess Industries Haemacure Corp. is engaged in the development, marketing and sales of surgical sealants and related medical devices. Its primary product is a fibrin sealant, a tissue sealant comprised of fibrinogen and thrombin extracted from human plasma. The fibrin sealant is used in surgical procedures to arrest bleeding and as an adjunct to wound healing. It was founded on August 19, 1991 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | 06.09.2013 |
Jazz Pharmaceuticals, Inc.
![]() Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Ausbildung von Dawn Benson
The University of North Carolina at Wilmington | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Haemacure Corp.
![]() Haemacure Corp. Industrial SpecialtiesProcess Industries Haemacure Corp. is engaged in the development, marketing and sales of surgical sealants and related medical devices. Its primary product is a fibrin sealant, a tissue sealant comprised of fibrinogen and thrombin extracted from human plasma. The fibrin sealant is used in surgical procedures to arrest bleeding and as an adjunct to wound healing. It was founded on August 19, 1991 and is headquartered in Montreal, Canada. | Process Industries |
Jazz Pharmaceuticals, Inc.
![]() Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |